1. RETRACTED ARTICLE: Histone methyltransferase SUV39H2 regulates LSD1-dependent CDH1 expression and promotes epithelial mesenchymal transition of osteosarcoma
   Yingying Miao et al, 2021, Cancer Cell International CrossRef
2. Upregulation of miR-146a by YY1 depletion correlates with delayed progression of prostate cancer
   Yeqing Huang et al, 2017, International Journal of Oncology CrossRef
3. GSK343 induces programmed cell death through the inhibition of EZH2 and FBP1 in osteosarcoma cells
   Xifeng Xiong et al, 2020, Cancer Biology & Therapy CrossRef
4. Increased EZH2 Levels in Anterior Cingulate Cortex Microglia Aggravate Neuropathic Pain by Inhibiting Autophagy Following Brachial Plexus Avulsion in Rats
   Xiang-Lei Meng et al, 2020, Neuroscience Bulletin CrossRef
5. Novel Natural Inhibitors Targeting Enhancer of Zeste Homolog 2: A Comprehensive Structural Biology Research
   Weihang Li et al, 2021, Frontiers in Oncology CrossRef
6. The master regulator FUBP1: its emerging role in normal cell function and malignant development
   Lydie Debaize et al, 2019, Cellular and Molecular Life Sciences CrossRef
7. Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) Function
   Aiste Dobrovolskaite et al, 2022, Journal of Medicinal Chemistry CrossRef
8. GSK343 modulates macrophage M2 polarization through the EZH2/MST1/YAP1 signaling axis to mitigate neurological damage induced by hypercalcemia in CKD mice
   Yaochen Cao et al, 2024, Cellular Signalling CrossRef
9. Autophagy Modulation as a Potential Therapeutic Strategy in Osteosarcoma: Current Insights and Future Perspectives
   Sergio Almansa-Gómez et al, 2023, International Journal of Molecular Sciences CrossRef
10. GSK343 induces autophagy and downregulates the AKT/mTOR signaling pathway in pancreatic cancer cells
    Hao Xu et al, 2019, Experimental and Therapeutic Medicine CrossRef
11. EZH2 promotes the progression of osteosarcoma through the activation of the AKT/GSK3β pathway
    Dongdong Wan et al, 2022, Clinical and Experimental Pharmacology and Physiology CrossRef
12. EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth
    Laura V. Bownes et al, 2021, PLOS ONE CrossRef
13. Tackling malignant melanoma epigenetically: histone lysine methylation
    Elias Orouji et al, 2018, Clinical Epigenetics CrossRef
14. FBP1 knockdown decreases ovarian cancer formation and cisplatin resistance through EZH2-mediated H3K27me3
    Xifeng Xiong et al, 2022, Bioscience Reports CrossRef
15. Decreased bone resorption in Ezh2 myeloid cell conditional knockout mouse model
    Perry C. Caviness et al, 2023, The FASEB Journal CrossRef
16. Classifying Osteosarcoma Using Meta-Analysis of Gene Expression
    Olivia Alge et al, 2018, 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) CrossRef
17. EZH2 Regulates the Correlation between Skin Regeneration and the Duration of Mechanical Stretch
    Jing Wang et al, 2021, Journal of Investigative Dermatology CrossRef
18. Iron overload increases the sensitivity of endometriosis stromal cells to ferroptosis via a PRC2-independent function of EZH2
    Yong Luo et al, 2024, The International Journal of Biochemistry & Cell Biology CrossRef